Apiam Animal Health Limited (ASX:AHX) FY2023 Trading Update
Apiam Animal Health Limited (ASX:AHX) today announced a market update ahead of the release of its financial results for the year ended 30 June 2023 (FY23).
Companies in the News
Biotech
Proteomics International Laboratories Ltd (ASX:PIQ) Proteomics Presents at 17th Bioshares Biotech Summit
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to delegates at the 17th Bioshares Biotech Summit on 25 July 2023.
Proteomics International Laboratories Ltd (ASX:PIQ) June 2023 Quarterly Activities Report
Proteomics International Laboratories Ltd (ASX:PIQ), a medical technology company at the forefront of precision medicine and predictive diagnostics, is pleased to provide the following update on its business activities for the three months to 30 June 2023 and subsequent to the period end.
Proteomics International Laboratories Ltd (ASX:PIQ) Promarker Pipeline - Oesophageal Cancer Diagnostic Update
Proteomics International Laboratories Ltd (ASX:PIQ) has been invited to present the latest results from its novel blood test for oesophageal adenocarcinoma at the 19th ISDE World Congress for Esophageal Diseases in Toronto, Canada, 8-10 September 2023.
VIDEO: Proteomics International Laboratories Limited (ASX:PIQ) MD Dr. Richard Lipscombe Talks about the PromarkerD Test and Agreement with Sonic Healthcare
In this interview, Dr. Richard Lipscombe, Managing Director of Proteomics International Laboratories Limited (ASX:PIQ), talks about the agreement recently entered into with Sonic Healthcare (USA).
Proteomics International Laboratories Ltd (ASX:PIQ) Sonic Healthcare USA Signs Licence for PromarkerD in the US
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce it has signed an exclusive licence agreement with Sonic Healthcare USA, a Division of Sonic Healthcare Ltd.
Proteomics International Laboratories Ltd (ASX:PIQ) World Endometriosis Congress - New Diagnostic Test Showcased
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce it will present its potential new blood test for endometriosis at the world's leading endometriosis conference.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Tumas Project Development Update - Positive Progress
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
Social Media
